David Ian Johnson's Net Worth
$711 Thousand
Who is David Ian Johnson?
David Ian Johnson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Alliqua, Inc., AquaMed Technologies, Inc., and Enveric Biosciences, Inc..
SEC CIK
David Ian Johnson's CIK is 0001563432
Past Insider Trading and Trends
2013 was David Ian Johnson's most active year for acquiring shares with 7 total transactions. David Ian Johnson's most active month to acquire stocks was the month of January. 2014 was David Ian Johnson's most active year for disposing of shares, totalling 4 transactions. David Ian Johnson's most active month to dispose stocks was the month of December. 2017 saw David Ian Johnson paying a total of $100,000.00 for 1,050,000 shares, this is the most they've acquired in one year. In 2014 David Ian Johnson cashed out on 80,350 shares for a total of $517,435.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alliqua, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +17.70% | 300K |
—
|
—
| 1.99M |
Jun 28
| |||
Form 4
| +41.86% | 500K |
—
|
—
| 1.69M |
Jun 23
| |||
Form 4
| +26.47% | 250K |
$0.40 | $100,000.00 | 1.19M |
Apr 3
| |||
Form 4
| +46.55% | 300K |
—
|
—
| 944.53K |
May 11
| |||
Form 4
| +10.25% | 59.93K |
—
|
—
| 644.53K |
Feb 9
| |||
Form 4
| +1.50% | 8.65K |
$2.92 | $25,258.00 | 584.6K |
Nov 6
| |||
Form 4
| -3.22% | -19.19K |
$5.35 | -$102,671.85 | 575.95K |
Jul 1
| |||
Form 4
| +1.71% | 10K |
$4.65 | $46,458.00 | 595.14K |
May 27
| |||
Form 4
| -3.40% | -20.59K |
$5.19 | -$106,862.10 | 585.14K |
Apr 1
| |||
Form 4
| -1.25% | -7.67K |
$5.29 | -$40,590.17 | 605.73K |
Mar 6
| |||
Form 4
| +95.72% | 300K |
—
|
—
| 613.41K |
Feb 6
| |||
Form 4
| -6.47% | -21.68K |
$5.30 | -$114,909.30 | 313.41K |
Jan 1
| |||
Form 4
| -5.78% | -20.55K |
$4.84 | -$99,471.68 | 335.09K |
Oct 1
| |||
Form 4
| -5.42% | -20.37K |
$5.74 | -$116,906.58 | 355.64K |
Jul 1
| |||
Form 4
| -5.09% | -20.19K |
$8.25 | -$166,534.50 | 376.01K |
Apr 1
| |||
Form 4
| +4.71% | 17.82K |
—
|
—
| 396.19K |
Mar 6
| |||
Form 4
| +1,240.83% | 350.15K |
$6.99 | -$134,522.55 | 378.37K |
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
| +100.00% | 617.28K |
—
|
—
| 1.23M |
Jun 28
| |||
Form 4
|
∞
| 617.28K |
—
|
—
| 617.28K |
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
| No matching records found | |||||||||
AquaMed Technologies, Inc. (NXGL) Snapshot price: $2.61
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Enveric Biosciences, Inc. (ENVB) Snapshot price: $0.5
CEO and Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FIREFLY NEUROSCIENCE, INC. (AIFF) No price found
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 557.88K |
—
|
—
| 557.88K |
Oct 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||